Diacylglycerol acyltransferase (DGAT) inhibitors

Diacylglycerol acyltransferase (DGAT) inhibitors are a class of biological substances that have gained significant attention in recent years due to their potential therapeutic benefits DGAT is an enzyme that plays a key role in the synthesis of triglycerides which are a major component of fats and oils By inhibiting the activity of DGAT these inhibitors have shown promise in the treatment of obesity diabetes and other metabolic disorders With their ability to regulate lipid metabolism DGAT inhibitors offer a potential avenue for developing novel therapies to address these prevalent health concerns Our company specializes in providing high-quality DGAT inhibitors for research and development purposes

Catalog Number	Chemical Name	CAS #	Price
EI-0178	Amidepsine A, Humcola sp.	169181-28-6	Online Inquiry
EI-0179	Amidepsine D, Humcola sp.	79786-34-8	Online Inquiry
EI-1722	PF-04620110	1109276-89-2	Online Inquiry

Application

Diacylglycerol acyltransferase (DGAT) inhibitors have a wide range of applications in the field of lipid metabolism research and drug development These inhibitors are commonly used to study the role of DGAT enzymes in lipid synthesis and storage and their potential as targets for therapeutic intervention in conditions such as obesity diabetes and cardiovascular diseases

In the pharmaceutical industry DGAT inhibitors are being investigated as potential drug candidates for the treatment of metabolic disorders By blocking the activity of DGAT enzymes these inhibitors can help to reduce the synthesis and accumulation of triglycerides which are key contributors to dyslipidemia and other metabolic abnormalities This makes DGAT inhibitors a promising avenue for developing novel therapies to improve lipid profile and metabolic health

Furthermore DGAT inhibitors are also valuable research tools in elucidating the mechanisms of lipid metabolism and energy homeostasis By studying the effects of these inhibitors in cellular and animal models scientists can gain insights into the complex interactions between DGAT enzymes lipid signaling pathways and metabolic regulation This knowledge can then be utilized to develop targeted strategies for modulating lipid metabolism and potentially combating metabolic disorders

Please note that all services are for research use only. Not intended for any clinical use.

Diacylglycerol acyltransferase (DGAT) inhibitors